Netanyahu Orders Escalation of Military Action Against Hizbollah Amid Iran Deal Concerns Microsoft and Anthropic in Advanced Talks for AI Chip Collaboration Following 5 Billion Investment Bond Market Suggests Fed May Shift to Tightening Bias Under Warsh Leadership Chinese Dividend Stocks Gain Favor Amid Limited Investment Options CurtissWright Executive Vice President Watts Reports 165640 Stock Sale Wall Street Awaits GameStop Chairman Ryan Cohens Next Move After eBay Rejects Takeover Bid Sequans Communications SA SQNS Q1 2026 Earnings Significant EPS Miss Amidst Revenue Uncertainty Stock Gains 37 OMC Q1 2026 Earnings EPS Exceeds Expectations as Stock Gains RDWR Q1 2026 Earnings EPS Misses Estimates by 1231 as Stock Rises 138 CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase DELL Q1 2026 Earnings EPS Surges Past Estimates Stock Rallies ICU Medical Inc ICUI Rises Modestly as Technicals Suggest RangeBound Trading Alphatec Holdings ATEC Slides 25 Key Levels to Watch Amid Market Pressure Lixte Biotechnology LIXT Holds Near Support After Slight Decline MetaVia Inc MTVA Tumbles 2286 as Selling Pressure Intensifies Below Critical Threshold Golar LNG GLNG Slips 23 as Traders Eye Support at 4859 After Resistance Test Bitcoin Surges Past 77000 Boosted by Iran Deal Optimism and Nasdaq Crypto Options Initiative Gladstone Land Corporation 600 Series C Cumulative Redeemable Preferred Stock LANDP Q1 2026 Earnings Narrower Loss Surprises as Preferred Coverage Held Steady VisionWave Warrants Dip 333 as Support at 096 Faces Test TRMB Q1 2026 Earnings EPS Surpasses Estimates by 79 Amid Strong Operational Execution Heritage Commerce Corp Q4 2025 Earnings Slight EPS Miss Flat Stock Reaction VTMX Q1 2026 Earnings Stellar EPS Beat Drives Modest Stock Uptick GeneDx Holdings Corp WGS Q1 2026 Earnings Deep EPS Miss Overshadows Progress TE Q1 2026 Earnings NarrowerthanExpected Loss as Company Advances Strategic Initiatives NAVN Q1 2026 Earnings Travel Management Firm Posts Surprise Profit Stock Jumps 7 Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline